These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Efficacy and toxicity of retreatment with gold salts: a retrospective review of 25 cases. Sagransky DM; Greenwald RA J Rheumatol; 1980; 7(4):474-8. PubMed ID: 6775078 [TBL] [Abstract][Full Text] [Related]
10. [Azapropazone and rheumatic combination therapy considering drug interactions: azapropazone aurothioglucose and azapropazone prednisolone]. Faust-Tinnefeldt GF; Geissler HE Arzneimittelforschung; 1978; 28(2):337-41. PubMed ID: 346022 [No Abstract] [Full Text] [Related]
11. Single dose pharmacokinetics of auranofin in rheumatoid arthritis. Blocka K; Furst DE; Landaw E; Dromgoole S; Blomberg A; Paulus HE J Rheumatol Suppl; 1982; 8():110-9. PubMed ID: 6813473 [TBL] [Abstract][Full Text] [Related]
12. [Gold therapy of rheumatic diseases]. Berndt H Z Arztl Fortbild (Jena); 1987; 81(9):416. PubMed ID: 3114970 [No Abstract] [Full Text] [Related]
13. Chrysiasis: the role of sun exposure in dermal hyperpigmentation secondary to gold therapy. Leonard PA; Moatamed F; Ward JR; Piepkorn MW; Adams EJ; Knibbe WP J Rheumatol; 1986 Feb; 13(1):58-64. PubMed ID: 3084781 [TBL] [Abstract][Full Text] [Related]
14. Quantitation of gold in skin in chrysiasis. Jeffery D; Biggs DF; Percy JS; Russell AS J Rheumatol; 1975 Mar; 2(1):28-35. PubMed ID: 1185732 [TBL] [Abstract][Full Text] [Related]
15. [Rare side effects of gold]. Stollenwerk R; Annefeld M; Schilling F; Dreher R Z Rheumatol; 1986; 45(3):107-10. PubMed ID: 2944309 [TBL] [Abstract][Full Text] [Related]
16. Cell-bound gold (CBG) in patients treated with aurothioglucose and with auranofin. A comparison of different methods of determination. van Riel PL; Gribnau FW; van de Putte LB J Rheumatol; 1983 Aug; 10(4):574-8. PubMed ID: 6413685 [TBL] [Abstract][Full Text] [Related]
17. Chrysiasis resulting from gold therapy in rheumatoid arthritis: identification of gold by x-ray microanalysis. Beckett VL; Doyle JA; Hadley GA; Spear KL Mayo Clin Proc; 1982 Dec; 57(12):773-7. PubMed ID: 6815384 [TBL] [Abstract][Full Text] [Related]
18. [Chrysotherapy in rheumatoid polyarthritis]. Suţeanu S; Moangă M Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1983; 35(2):107-12. PubMed ID: 6139855 [No Abstract] [Full Text] [Related]
19. [2 cases of kidney damage during the treatment with gold preparations]. Wanic-Kossowska M; Turczak-Bierła I; Grzegorzewska A Przegl Lek; 1990; 47(11):788-90. PubMed ID: 2129137 [No Abstract] [Full Text] [Related]
20. Cigarette smoking and the clinical outcome of gold therapy in rheumatoid arthritis. Lewis D; Capell HA; McNeil CJ; Smith WE; Brown DH J Rheumatol; 1984 Feb; 11(1):111-2. PubMed ID: 6422040 [No Abstract] [Full Text] [Related] [Next] [New Search]